
|Videos|November 30, 2018
CDK4/6 Inhibition's Role in HR+ Metastatic Breast Cancer
Advertisement
Episodes in this series

Now Playing
Transcript:
Transcript Edited for Clarity
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
3
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5
















































































